Figure 1. Comparison of the Schlafen Family Deduced Amino Acid Sequences
Comparison of the deduced amino acid sequences of the four complete Schlafen family genes. Conserved amino acids are boxed while identical sequences are shaded. The underlined regions define conserved sequence blocks identified using BlockMaker. The asterisk marks the location of the methionine residues that potentially could reside at the amino terminal end of each protein.
expressing the AND TCR specific for cytochrome c, and screen a mouse genomic library, resulting in the isolation of a series of clones that encode all or part of Slfn3, 4, the H-2 h4 haplotype (AND.4R mice), maturation is halted at the CD4 ϩ 8 ϩ double-positive (DP) stage, and these and 6, as well as one additional clone that we have designated Slfn7. Based on these data, we estimate that mice lack mature CD4 or CD8 SP cells (Kersh and Hedrick, 1995). In contrast, development is skewed toward the Slfn family consists of at least seven distinct genes. Each Slfn cDNA encodes a single long open reading the positive selection of CD4 SP cells in AND mice expressing H-2 b (AND.B6 mice), and these cells constitute frame that is initiated by a consensus translational initiation codon (Kozak, 1986 ) and is preceded upstream by 50% of all thymocytes (Kaye et al., 1989 (Kaye et al., , 1992 .
To identify genes that are upregulated as a result one or more in frame termination codons. In three of the genes (Slfn1, 2, and 4), an internal Kozak initiation of positive selection, a subtractive hybridization was performed using thymus cDNA libraries prepared from codon is found corresponding to amino acid position 28 of SLFN1, and it is unclear which initiation codon AND.B6 and AND.4R mice. The objective was to characterize genes from the AND.B6 library not in common is utilized by the mature protein; however, since the upstream methionine codon is missing from Slfn3, it is with the AND.4R library. This led to the isolation of a novel developmentally regulated gene that is preferenconceivable that all four proteins preferentially use this internal initiation site. tially expressed in AND.B6 compared to AND.4R thymocytes ( Figure 2A ). The nucleotide and deduced amino The four conceptual SLFN proteins contain a core region that is nearly identical, spanning amino acids acid sequences of this gene, which we have named Schlafen1 (Slfn1), were used to query the expressed 213-336 of SLFN1; however, the N terminus for each of the four proteins differs significantly. The exception is sequence tag (EST) databases using the gapped-basic local alignment search tool (BLAST) (Altschul et al., between SLFN3 and 4, which are very similar except for a deletion of 10 amino acids in SLFN4. Interestingly, 1997). This approach ultimately led to the isolation of three additional Slfn genes (Figure 1 ) that collectively while SLFN1 and 2 are almost identical in size, SLFN3 and 4 are nearly twice as large, possessing a carboxybear identity or similarity to 53 EST entries. Based on a sequence comparison, these ESTs have been assigned terminal protein sequence of approximately 200 amino acids not found in SLFN1 or 2. We refer to these regions, to six unique genes. Expression of each of these genes has been confirmed by rtPCR (below and data not based on the amino acid sequence of SLFN3, as domain I (amino acids 1-186), II (amino acids 187-309), and III shown). A portion of the Slfn3 cDNA was also used to In no case were multiple members of a motif "family" databases, we found that the nucleotide sequences of present. We also used Block Maker (Henikoff et al., 1995) Slfn1-4 do not share meaningful similarities to any known to identify two conserved motifs that were defined using genes. In contrast, a number of significant matches were SLFN1-4, along with the partial sequence for the human found when the deduced SLFN amino acid sequences homolog of SLFN5. These motifs, which are underlined were used to query the nonredundant protein databases in Figure 1 , were used to query the nonredundant protein using BLASTp. In each case, strong matches were found databases using the local alignment of multiple alignin the right inverted terminal repeat (ITR) of Vaccinia, ments (LAMA) search tool (Pietrokovski, 1996) . Again, as Variola, and Cowpox viruses. Located within this region we saw using the individual sequences as query vectors, are the putative proteins referred to as B2R, 20.9k, B3, there were no significant matches found. H3R, and H5R. Upon closer examination, it was found that the nucleotide sequences of these viral isolates are very similar to those for the Slfn family; however, with
Expression of Schlafen Family Members
The Slfn genes are expressed at relatively low levels as the exception of B2R, the similarity is not found within a single ORF but rather is distributed through all three detected by Northern blot analysis (Figure 2A ; data not shown), so we have utilized rtPCR to measure the exORFs. We suspect that a member of the Slfn family was captured early on in the evolution of this viral family and pression of each gene. Primer cocktails were used that target the nucleotide sequences encoding the variable has been slowly decaying over time. Nonetheless, there exists the possibility that one or more of the putative domain I and conserved domain II of each gene. In this way, we could accomplish the simultaneous amplificavector contains a ribosomal entry site that allows translation of both the gene of interest and the downstream tion of all four genes in a single reaction. As a control, an additional primer set specific for ␤ actin was included neomycin phosphotransferase message. As a direct consequence, all transfected cells that are neomycin in all reactions. We note that the primer sets for Slfn3 and 4 also amplify Slfn6 and 7, respectively. resistant must also express Slfn. Figure 3A is a pictorial of three independent experiAs shown in Figure 2B , Slfn1, 2, and 4/7 were found to be mainly expressed in the thymus, lymph node, and ments using this expression system. In each case, transfection of NIH-3T6 cells with pCIN-4 alone resulted in spleen. There was low-level expression in other tissues, especially the lung, but these samples probably coninnumerable drug resistant colonies, while no colonies could be detected in mock transfected cultures. Howtained circulating lymphocytes. The highest level of Slfn3/6 expression was detected in the testis, although ever, cells transfected with pCIN-4 vectors encoding Slfn genes had a variable effect on the generation of there was a small amount detected in the thymus and heart. Complement-mediated depletion of thy-1 ϩ spledrug-resistant colonies. With Slfn1, there was a noticeable reduction in the number of colonies recovered relanocytes removed most of the Slfn1 signal (data not shown), demonstrating that much of the expression can tive to vector alone. However, for Slfn2 and 3, there was a dramatic reduction in the number of colonies be attributed to the T cell subset. Conversely, we failed to find expression of Slfn4/7 in purified T cells (Figure observed, with only a single colony produced in all three independent transfections with Slfn3. Similar results 2D), and presumably expression in the spleen and lymph nodes can be attributed to other cell types.
were also obtained using the thymoma AKR1G1 in a colony formation assay (data not shown). This presents We next examined expression of each gene in the four major thymic subsets: immature CD3 Ϫ CD4 Ϫ CD8 Ϫ an enigma, since AKR1 expresses a member of the Slfn family that is amplified by the Slfn3 primer set (data not triple-negative cells (TN), CD4 ϩ CD8 ϩ DP cells, and mature CD4 or CD8 cells. In order to quantitate the relative shown), and yet transfection appears to prevent colony formation. We are currently attempting to determine expression in each subset, serial 10-fold dilutions of cDNA were PCR amplified, and all signals were normalized to whether the detected transcript might encode a mutant form of Slfn3 or whether our primers are detecting the ␤ actin. As shown in Figure 2C , Slfn1 was upregulated approximately 100-fold during the DP to SP transition.
closely related Slfn6, which we have yet to assay for growth disruption. Alternatively, colony formation may Slfn2 expression also increased during this transition, but the increase was found to be only 5-to 10-fold. depend on the relative level of Slfn3 expression. The above data are consistent with the possibility that Interestingly, Slfn4/7expression decreased during development, being the highest in TN cells and barely Slfn family members arrest cell growth, or cause apoptosis, or both. To account for the loss of Slfn-expressing detectable in SP cells. Finally, Slfn3/6 message is expressed very weakly, but the level of its expression does cells, we placed Slfn1 under control of the tetracycline operator (Shockett et al., 1995) and introduced this synnot appear to change dramatically. Collectively, these data show that Slfn1, 2, and 4/7 are preferentially exthetic gene into NIH-3T3 fibroblasts expressing the tetracycline responsive transactivator (S2-6 cells, a generpressed in the lymphoid lineage and are differentially regulated during thymocyte development. ous gift from David Schatz). In these cells, expression of the transgene is suppressed in the presence of tetraWe also examined the expression of Slfn genes under conditions of T cell activation. Peripheral T cells were cycline and is induced following tetracycline removal. To test the effect of Slfn1 on cell growth, expression purified and left untreated or subjected to plate-bound anti-CD3 in the presence or absence of CD28 costimulawas induced for periods of 24, 48, or 72 hr. In preliminary experiments, we found a strong inhibition of cell growth tion for either 1, 2, or 3 days. Untreated T cells expressed both Slfn1 and 2 but not 3/6 or 4/7 ( Figure 2D ). Following in the Slfn1-transfected clone but not in S2-6 clones.
To determine the percentage of cells that were in G0/ T cell activation, there was an increase in the expression of Slfn3/6 and 4/7 and a concomitant decrease in the G1, S, and G2/M at different times after Slfn1 induction, the cells were stained with propidium iodide to measure expression of Slfn1 and 2 ( Figure 2E ). Interestingly, these changes were more pronounced following ligation of DNA content, and DNA synthesis was assessed by measuring the incorporation of a single pulse of BrdU. both CD3 and CD28. This may indicate that the expres- Figure 3B depicts results that are representative of sion of the Slfn gene family is linked to cell growth or three independent experiments. Prior to induction, the blastogenesis.
cell density in each culture was similar for the parental S2-6 cells and the Slfn1 transfected clone, 18-9. ApproxSlfn Inhibits Cell Growth imately 30% of the cells were in S phase, and 9% were Early attempts to produce cell lines that constitutively in G 2 /M. Over the course of the experiment, the percentexpressed Slfn1 were unsuccessful. We also found that age of control S2-6 cells in S and G 2 /M remained relaneither antigen-specific T cell clones nor primary T cell tively constant until the cells reached confluence at 72 lineage transformed cell lines expressed Slfn1 (data not hr. Once confluent, these cells became quiescent and shown). Since we had already found a tentative link the percentage in S phase dropped. Conversely, inducbetween expression of the Slfn genes and cell growth tion of Slfn1 in 18-9 cells reduced the percentage in S (see above), we reasoned that ectopic expression of the phase within 24 hr, and there was no further increase Slfn family might alter normal cell growth. To test this in the number of cells recovered after this time point. hypothesis, cDNA clones for Slfn1-3 were cloned into Interestingly, the percentage of 18-9 cells in S phase increased at 72 hr, even though the density remained the expression vector pCIN-4 (Rees et al., 1996 ). This lines were identified (Slfn14 and Slfn17). Only the Slfn14 line (subsequently referred to as CD2.Slfn1) expressed Collectively, these data demonstrate that Slfn1 inhibits the G1 to S phase transition of the cell cycle. We dethe transgene. The level to which the transgene is expressed is slightly less than that detected for the endogtected no change in cell viability at any point during Slfn1 expression, as assessed by either trypan blue uptake or enous message in normal peripheral lymphocytes (Figure 4A) . However, in the thymus, expression of the the quantitation of subdiploid amounts of DNA. This appears to exclude apoptosis as the method by which transgene predominates, and presumably reflects the loss of the SP cells (see below), which are the primary fibroblast growth is disrupted. We have been unable to carry out similar experiments with Slfn2 or Slfn3 because source of endogenous Slfn1 message ( Figure 2C ). We emphasize that Slfn1 is not overexpressed in CD2.Slfn1 we cannot obtain stable S2-6 transfectants. The basal expression of Slfn2 or 3 in this system may be sufficient mice. Rather, we have altered the kinetics of its expression such that DP thymocytes express levels normally to disrupt cell growth.
found in SP thymocytes. The FACS profiles depicted in Figure 4B are represenEctopic Early Expression of Slfn1 Disrupts tative of several independent experiments, while the Thymic Development number of cells in each subset were calculated from the Based on the observations that Slfn1 causes a cell cycle collective data of 11 littermate, 13 CD2.Slfn1 ϩ/Ϫ , and 7 arrest, we wanted to determine whether SLFN partici-CD2.Slfn1 ϩ/ϩ mice. All mice ranged in age from 40-50 pates in regulating thymocyte expansion or maintaining days, and identical quadrants were set in each experimature thymocytes in a quiescent state. To accomplish ment. As shown, early expression of Slfn1 caused a this, we produced transgenic mice using a (Wu et al., 1991a) , it is likely that these cells are cycling, and they would therefore be expected to instage of development ( Figure 5C ). This is the same stage at which RAG-deficient thymocyte development crease the percentage of BrdU ϩ cells in the DN subset. Thus, the overall inhibition of DN division may be greater is blocked and is consistent with the idea that ectopic Slfn1 expression interferes with the proliferative expanthan shown.
Immature DN thymocytes are developmentally heterosion of CD25 Ϫ 44 Ϫ thymocytes. Interestingly, there was also a reduction in the percentage of CD25 Ϫ 44 ϩ cells. geneous, and these cells can be further fractionated based on the expression of CD25 and CD44. These It may be that Slfn1 expression also blocked the IL-7-driven proliferation of these cells. Alternatively, excess markers alone define four distinct subsets within the DN subset ( Figure 5C ). The most immature cells express CD25 ϩ cells may have inhibited the expansion of the CD25 Ϫ 44 ϩ cells through an unspecified feedback mech-CD44 only, and these cells divide in response to intrathymic IL-7 (Peschon et al., 1994) . As the cells mature, anism. The morphological changes associated with apopto-7D) and peripheral lymphocytes ( Figure 7E ). No phenotypic differences between Slfn1-deficient mice and their sis occur relatively late in the death pathway, whereas earlier stages of apoptosis can be detected by measur-LMC counterparts have been noted thus far, and we conclude that Slfn1 is not required for these aspects of ing changes in the proton gradient maintained across lymphoid physiology. We suspect that one of the other the inner mitochondrial membrane. As cells undergo family members may indeed be compensating for the apoptosis, the membrane potential drops, and this can loss of Slfn1. In particular, Slfn2 is similar to Slfn1 in be measured as a reduction in the intensity of DiOC 6 both size and expression. We are currently attempting staining (Zamzami et al., 1995) . As shown in the experito address this issue by producing mice deficient for ment depicted in Figure 6B , 32% of the viable cells from multiple Slfn family members. CD2.Slfn1 ϩ/ϩ mice were DiOC 6 low as compared to 11% in thymocytes from a LMC mouse. Thus, using three independent measures, we found a significant increase Discussion in the number of apoptotic thymocytes isolated from Slfn1 transgenic mice. In each case, the phenotype of We have identified a novel gene family that consists, in CD2.Slfn1 ϩ/ϩ mice was an exaggeration of that seen mice, of at least seven highly related members. These in CD2.Slfn1 ϩ/Ϫ heterozygotes. We conclude that the genes encode proteins that fall into two distinct groups observed reduction in thymic cellularity appears to be based on size; a short form encoded by Slfn1 and 2 and a consequence not only of reduced cell division but of a long form encoded by Slfn3 through 7. The prototype increased cell death. member of this family, Slfn1, was isolated in a screen designed to identify genes that are transcriptionally upregulated during the process of positive selection.
Slfn1-Deficient Mice
While we have demonstrated a large increase in the In order to determine whether Slfn1 expression is reexpression of this gene during thymocyte development, quired for normal regulation of thymocyte expansion, we also found that there is a substantial difference in the expression of at least two other family members we produced mice with a homozygous deficiency in and T cell development.
or RNeasy spin columns (Qiagen) following the manufacturer's protocol. For Northern blot analysis, 30 g of total RNA was resolved through a 1% formaldehyde gel, transferred to NitroPure nitrocelluExperimental Procedures lose (Micron Separations Incorporated), and hybridized to a radiolabeled Slfn1 cDNA probe. For rtPCR analysis, total RNA was treated Isolation and Sequencing of Schlafen cDNAs PolyA ϩ RNA from AND.B6 and AND.4R thymocytes was isolated with Rnase-free Dnase and converted to cDNA with AMV reverse transcriptase. Two hundred nanograms (or 2 ϫ 10 5 cell equivalents using a QuickPrep Micro mRNA purification kit (Pharmacia). Complementary DNA libraries were prepared using a Superscript plasmid in the case of the thymocyte subsets) of the resulting samples were subjected to 30 cycles of the PCR in a 25 L buffered solution cDNA library kit (GIBCO-BRL) according to the manufacturer's recommended protocol. Inserts excised from the plasmid backbone containing 1.5 mM Mg ϩϩ and either 10 pmoles (SlfnORF5, Slfn2B.5, Slfn3D.5, Slfn4.5, ␤-Actin3, and ␤-Actin5) or 30 pmoles (Slfn4/B) were used for subtractive hybridization using a previously described protocol (Hara et al., 1994) . Subtracted material was subcloned into primer. For analysis of Slfn1-deficient mice, 10 pmoles each of 18.RTP3, 18.RTP5, ␤-Actin3, and ␤-Actin5 primers were used. The pBK-CMV (Stratagene), and a single cDNA clone encoding Slfn1 (GenBank AF099972) was recovered. Subclones of the Slfn1 cDNA individual cycles were 20 sec at 95ЊC, 40 sec at 57ЊC, and 60 sec at 72ЊC. One half of the amplified material was resolved through an were sequenced on both strands using the Sanger dideoxy chain termination method. The orientation and placement of each subagarose gel containing EtBr and the image captured electronically using IPLab Gel H software (Signal Analytics). In the case of acticlone was determined by restriction mapping or by sequencing additional overlapping clones.
vated T cells, a profile plot representing band intensity was generated for each PCR product series (for example, Slfn1 at each time To isolate Slfn2 and 3, a C57BL/6 thymocyte cDNA library was prepared in the vector UNI-ZAP (Stratagene). The library was point) using IPLab Gel H software. The area (A) of each peak was then calculated. For each time point (for example, undiluted cDNA allowed to adhere overnight. Cells were then washed twice and fresh media lacking tetracycline was added. Thirty minutes prior to at time 0), the area taken up by actin was normalized relative to the area of the most intense actin band in the series. The resulting harvesting, the cultures were pulsed with 10 M BrdU. After staining fixed cells with 10 L FITC-conjugated anti-BrdU and 5 g/ml pro-"normalization coefficient" was used to normalize the areas calculated for the other Slfn products in that cDNA sample. pidium iodide (Dolbeare et al., 1983), they were analyzed by flow cytometry. Oligonucleotides All oligonucleotides used in this study were synthesized by the
